Equities Analysts Issue Forecasts for Biogen FY2025 Earnings
Biogen Inc. (NASDAQ:BIIB – Free Report) – Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Biogen in a research note issued on Thursday, February 13th. Cantor Fitzgerald analyst E. Schmidt now forecasts that the biotechnology company will post earnings per share of $16.13 for the year, down from their previous estimate […]
